Zerhouni Elias A.'s Form 4 filing
Opko Health, Inc. (OPK) · filed Jan 5, 2024
- Accession no.
- 0000950170-24-002542
- Filed
- Jan 5, 2024
- Trade date
- Jan 5, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $514.1K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zerhouni Elias A.CIK 0001478398 | Director, Officer (Vice Chairman and President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2024 | Common Stock | PPurchaseAcquired | +17,000 | $0.87 | +$14,790 | 19,794,514 | Indirect | |
| Jan 5, 2024 | Common Stock | PPurchaseAcquired | +33,300 | $0.91 | +$30,303 | 19,827,814 | Indirect | |
| Jan 5, 2024 | Common Stock | PPurchaseAcquired | +100,000 | $0.93 | +$93,000 | 19,927,814 | Indirect | |
| Jan 5, 2024 | Common Stock | PPurchaseAcquired | +400,000 | $0.94 | +$376,000 | 20,327,814 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.